Biotechnology Stocks
| # | Letzte 7 Tage | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4028 | ONCY Oncolytics Biotech Inc. - Common Stock | 0.54 USD | -10.00% | -15.62% | -32.50% | -57.81% | 68.86 M USD | ||
| 4034 | FBIO Fortress Biotech, Inc. - Common Stock | 2.10 USD | +2.94% | +1.45% | -21.35% | -26.83% | 70.04 M USD | ||
| 4035 | MAIA MAIA Biotechnology, Inc. Common Stock | 1.16 USD | 0.00% | -4.13% | -14.71% | -44.23% | 70.56 M USD | ||
| 4043 | HRTX Heron Therapeutics, Inc. - Common Stock | 0.36 USD | -5.26% | 0.00% | +5.88% | -73.72% | 68.35 M USD | ||
| 4044 | CSBR Champions Oncology, Inc. - Common Stock | 4.98 USD | +2.05% | -1.19% | +0.61% | -22.43% | 69.31 M USD | ||
| 4050 | SPRO Spero Therapeutics, Inc. - Common Stock | 1.14 USD | -2.56% | -9.52% | -5.00% | -51.49% | 66.39 M USD | ||
| 4052 | XBIT XBiotech Inc. - Common Stock | 2.20 USD | +0.46% | 0.00% | +0.46% | -17.91% | 67.07 M USD | ||
| 4054 | NTHI NeOnc Technologies Holdings, Inc. - Common Stock | 2.53 USD | -6.64% | -17.32% | -36.75% | -71.15% | 65.62 M USD | ||
| 4059 | RNTX Rein Therapeutics, Inc. - Common Stock | 0.76 USD | -3.80% | -10.59% | -13.64% | -30.91% | 65.56 M USD | ||
| 4061 | HYFT MindWalk Holdings Corp. - Common Stock | 1.43 USD | -4.67% | +7.52% | +6.72% | -30.24% | 66.80 M USD | ||
| 4075 | PLRX Pliant Therapeutics, Inc. - Common Stock | 1.01 USD | +2.02% | -3.81% | -9.82% | -34.42% | 62.54 M USD | ||
| 4081 | RNXT RenovoRx, Inc. - Common Stock | 1.35 USD | -1.46% | -12.90% | -37.21% | +12.50% | 60.92 M USD | ||
| 4083 | MREO Mereo BioPharma Group plc - American Depositary Shares | 0.38 USD | +8.57% | +2.70% | +46.15% | -80.71% | 60.68 M USD | ||
| 4084 | IBIO iBio, Inc. - Common Stock | 0.91 USD | -9.90% | -18.02% | -30.00% | -60.43% | 58.52 M USD | ||
| 4086 | ELOX Eloxx Pharmaceuticals, Inc. | 15.25 USD | +2.49% | -2.93% | -4.57% | +52.50% | 61.56 M USD | ||
| 4088 | GOSS Gossamer Bio, Inc. - Common Stock | 9.87 USD | -3.05% | -9.70% | +6480.00% | +302.86% | 60.31 M USD | ||
| 4091 | PDSB PDS Biotechnology Corporation - Common Stock | 1.04 USD | -2.80% | +46.48% | +246.67% | +4.00% | 58.21 M USD | ||
| 4092 | KLRS Kalaris Therapeutics, Inc. - Common Stock | 2.51 USD | -1.95% | -10.68% | -31.42% | -75.46% | 59.75 M USD | ||
| 4113 | ALDX Aldeyra Therapeutics, Inc. - Common Stock | 0.95 USD | -1.04% | -26.36% | -37.91% | -83.27% | 57.31 M USD | ||
| 4114 | CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 0.90 USD | -4.26% | -8.16% | -52.88% | -51.87% | 56.68 M USD |
Nachrichten Biotechnology Stocks
Kymera Therapeutics: Raymond James startet Coverage mit „Outperform“-Rating
Raymond James startet Coverage für Nektar-Aktie mit "Market Perform"
Raymond James nimmt Coverage für Palisade Bio mit "Outperform" auf
Raymond James bestätigt Liquidia-Rating trotz rechtlicher Unsicherheiten
Ginkgo Bioworks gewährt NSF X-Labs Zugang zu autonomem Labor
AbCellera präsentiert Phase-1/2-Daten zu Medikamentenkandidaten gegen Menopause-Beschwerden
Quantum-Si: Nachweis von 19 Aminosäuren markiert wichtigen Meilenstein für Proteus-Plattform
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |